glp-1 logo glp 1 Friendly (1" round label) GLP-1 Rewrites CPG Strategy Elysion Health | GLP-1 |

EPP: realworld and longterm observational outcomes Multiple cohorts demonstrate sustained benefit: an increase of approximately 6.1 hours/week of reported light exposure and a ~14% improvement in EPPspecific QoL

Additionally, it can be beneficial for individuals suffering from chronic fatigue syndrome, fibromyalgia, and other chronic illnesses

(PubMed) Aune D, Keum N, Giovannucci E, et al

The CITRIS-ALI trial evaluated the administration of VitC alone in sepsis, associated with acute respiratory distress syndrome (ARDS) patients, in a dose of 200 mg/kg/day (about 14 g/day to a 70 kg patient)

Mol Cell 6: 861871

BMC Endocrine Disorders, 23(1)